Meta-analysis of sentinel node imprint cytology in breast cancer

British Journal of Surgery

Volumn 92, Issue 9, 2005, Pages 1068-1080

  Tew, K ^a   Irwig, L ^b   Matthews, ^a   Crowe, P ^a,c   Macaskill, P ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FROZEN SECTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; METASTASIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SYSTEMATIC REVIEW; TUMOR VOLUME;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 24644467289     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5139     Document Type: Article

References (66)

1. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-399.
2. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84: 138-142.
3. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991-993.
4. Gulec SA, Su J, O'Leary JP, Stolier A. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg 2001; 67: 529-532.
5. Nagashima T, Suzuki M, Yagata H, Nikaido T, Horiuchi F, Koda K et al. Intraoperative cytologic diagnosis of sentinel node metastases in breast cancer. Acta Cytol 2003; 47: 1028-1032.
6. Tanis PJ, Boom RP, Koops HS, Faneyte IF, Peterse JL, Nieweg OE et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001; 8: 222-226.
7. Turner RR, Hansen NM, Stern SL, Giuliano AE. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 1999; 112: 627-634.
8. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
9. Weiser MR, Montgomery LL, Susnik B, Tan LK, Borgen PI, Cody HS. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 2000; 7: 651-655.
10. Scucchi LF, Di Stefano D, Cosentino L, Vecchione A. Value of cytology as an adjunctive intraoperative diagnostic method. An audit of 2250 consecutive cases. Acta Cytol 1997; 41: 1489-1496.
11. Zgajnar J, Frkovic-Grazio S, Besic N, Hocevar M, Vidergar-Kralj B, Gerljevic A et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients - results of a large series. J Surg Oncol 2004; 85: 82-86.
12. Leidenius MH, Krogerus LA, Toivonen TS, Von Smitten KJ. The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer. J Surg Oncol 2003; 84: 68-73.
13. Cserni G. Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2003; 69: 419-423.
14. Creager AJ, Geisinger KR, Perrier ND, Shen P, Shaw JA, Young PR et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg 2004; 239: 61-66.
15. Greenhalgh T. How to read a paper: the Medline database. BMJ 1997; 315: 180-183.
16. Cochrane methods groups on systematic review of screening and diagnostic tests: recommended methods, updated 6 June 1996. http://www.cochrane.org/ cochrane/sadtdoc1.htm 1996 [accessed 15 March 2004]
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138: W1-W12.
18. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann Intern Med 2003; 138: 40-44.
19. Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 2002; 96: 225-231.
20. Liang R, Craik J, Juhasz ES, Harman CR. Imprint cytology versus frozen section: intraoperative analysis of sentinel lymph nodes in breast cancer. ANZ J Surg 2003; 73: 597-599.
21. Lau J. Meta-Test version 0.6. New England Medical Centre: Boston, 1997.
22. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12: 1293-1316.
23. Macaskill P. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol 2004; 57: 925-932.
24. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002; 21: 589-624.
25. Ravichandran D, Kocjan G, Falzon M, Ball RY, Ralphs DN. Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma. Eur J Surg Oncol 2004; 30: 238-242.
26. Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 2003; 10: 1166-1170.
27. Aihara T, Munakata S, Morino H, Takatsuka Y. Touch imprint cytology and immunohistochemistry for the assessment of sentinel lymph nodes in patients with breast cancer. Eur J Surg Oncol 2003; 29: 845-848.
28. Munakata S, Aihara T, Morino H, Takatsuka Y. Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma. Cancer 2003; 98: 1562-1568.
29. Sauer T, Engh V, Hoick AM, Sorpebol G, Heim M, Furu I et al. Imprint cytology of sentinel lymph nodes in breast cancer. Experience with rapid, intraoperative diagnosis and primary screening by cytotechnologists. Acta Cytol 2003; 47: 768-773.
30. Mullenix PS, Carter PL, Martin MJ, Steele SR, Scott CL, Walts MJ et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 2003; 185: 420-424.
31. Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003; 185: 425-428.
32. Bochner MA, Farshid G, Dodd TJ, Kollias J, Gill PG. Intraoperative imprint cytologie assessment of the sentinel node for early breast cancer. World J Surg 2003; 27: 430-432.
33. Beach RA, Lawson D, Waldrop SM, Cohen C. Rapid immunohistochemistry for cytokeratin in the intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma. Appl Immunohistochem Mol Morphol 2003; 11: 45-50.
34. Cohen C, Alazraki N, Styblo T, Waldrop SM, Grant SF, Larsen T. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl Immunohistochem Mol Morphol 2002; 10: 296-303.
35. Yu JC, Hsu GC, Liu YC, Sheu LF, Li SH, Chao TY. Sentinel node biopsy in early breast cancer in Taiwan. World J Surg 2002; 26: 1365-1369.
36. Shiver SA, Creager AJ, Geisinger K, Perrier ND, Shen P, Levine EA. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg 2002; 184: 424-427.
37. Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Shaw JA et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol 2002; 15: 1140-1147.
38. Baitchev G, Gortchev G, Todorova A. Intraoperative sentinel lymph node examination by imprint cytology during breast surgery. Curr Med Res Opin 2002; 18: 185-187.
39. Llatjos M, Castella E, Fraile M, Rull M, Julian FJ, Fuste F et al. Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma: accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer 2002; 96: 150-156.
40. Henry-Tillman RS, Korourian S, Rubio IT, Johnson AT, Mancino AT, Massol N et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 2002; 9: 333-339.
41. Kane JM III, Edge SB, Winston JS, Watroba N, Kurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001; 8: 361-367.
42. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2001; 67: 86-91.
43. Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000; 66: 574-578.
44. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 2000; 87: 597-601.
45. Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999; 35: 14-18.
46. Noguchi M, Bando E, Tsugawa K, Miwa K, Yokoyama K, Nakajima K et al. Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat 1999; 57: 221-229.
47. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 1999; 86: 1346-1348.
48. Ku NN. Pathologic examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin NAm 1999; 8: 469-479.
49. Jain P, Kumar R, Anand M, Asthana S, Deo SV, Gupta R et al. Touch imprint cytology of axillary lymph nodes after neoadjuvant chemotherapy in patients with breast carcinoma. Cancer 2003; 99: 346-351.
50. Miller AR, Thomason VE, Yeh IT, Alrahwan A, Sharkey FE, Stauffer J et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002; 9: 243-247.
51. Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 2003; 77: 9-14.
52. Smidt ML, Besseling R, Wauters CA, Strobbe LJ. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. Br J Surg 2002; 89: 1290-1293.
53. Salem AA, Douglas-Jones AG, Sweetland HM, Newcombe RG, Mansel RE. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. Br J Surg 2002; 89: 1386-1389.
54. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Herman C et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999; 6: 95-101.
55. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999; 65: 500-505.
56. Ahmad N, Ku NN, Nicosia SV, Smith PV, Muro-Cacho CA, Livingston S et al. Evaluation of sentinel lymph node imprints in breast cancer: role of intraoperative cytokeratins immunostaining in breast cancer staging. Acta Cytol 1998; 42: 1218 (Abstract).
57. Ku NN, Ahmad N, Smith PV, Cox CE, Shons A, Reintgen DS et al. Intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Acta Cytol 1997; 41: 1606-1607 (Abstract).
58. Diamond GA. Limited assurances. Am J Cardiol 1989; 63: 99-100.
59. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061-1066.
60. Bochner MA, Kollias J, Gill PG, Farshid G, Dodd TJ. Implication of intraoperative sentinel node imprint cytology for consent in the SNAC Trial. ANZ J Surg 2004; 74: 105-107.
61. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536-541.
62. Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001; 20: 230-237.
63. Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J et al. NSABP-32: phase III, randomized trial comparing axillary resection with sentinel lymph node dissection: a description of the trial. Ann Surg Oncol 2004; 11(Suppl): 208S-210S.
64. Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335: 1565-1568.
65. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997; 4: 447-451.
66. Sterne JC, Smith GD. Sifting the evidence: what's wrong with significance tests? BMJ 2001; 322: 226-231.